- Home
- HBT vs PAHC Comparison
HBT vs PAHC Comparison
Compare HBT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBT
- PAHC
- Stock Information
- Founded
- HBT 1920
- PAHC 1946
- Country
- HBT United States
- PAHC United States
- Employees
- HBT N/A
- PAHC N/A
- Industry
- HBT Major Banks
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- HBT Finance
- PAHC Health Care
- Exchange
- HBT Nasdaq
- PAHC Nasdaq
- Market Cap
- HBT 706.0M
- PAHC 746.5M
- IPO Year
- HBT 2019
- PAHC 2014
- Fundamental
- Price
- HBT $23.55
- PAHC $22.47
- Analyst Decision
- HBT Hold
- PAHC Sell
- Analyst Count
- HBT 6
- PAHC 4
- Target Price
- HBT $24.80
- PAHC $20.00
- AVG Volume (30 Days)
- HBT 36.7K
- PAHC 235.5K
- Earning Date
- HBT 04-21-2025
- PAHC 05-07-2025
- Dividend Yield
- HBT 3.57%
- PAHC 2.14%
- EPS Growth
- HBT 6.07
- PAHC 140.17
- EPS
- HBT 2.38
- PAHC 0.78
- Revenue
- HBT $227,041,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- HBT $7.67
- PAHC $27.84
- Revenue Next Year
- HBT $3.26
- PAHC $10.22
- P/E Ratio
- HBT $9.89
- PAHC $28.79
- Revenue Growth
- HBT 1.69
- PAHC 19.12
- 52 Week Low
- HBT $18.16
- PAHC $16.06
- 52 Week High
- HBT $26.25
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- HBT 55.85
- PAHC 68.82
- Support Level
- HBT $22.82
- PAHC $18.89
- Resistance Level
- HBT $23.81
- PAHC $19.65
- Average True Range (ATR)
- HBT 0.64
- PAHC 0.81
- MACD
- HBT 0.07
- PAHC 0.61
- Stochastic Oscillator
- HBT 75.14
- PAHC 93.56
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.